Dr. Thanh Nho Do’s research focuses on a range of cutting-edge robotic innovations designed to transform healthcare and human-computer interaction. By integrating soft robotics and bionics into cancer surgery and stroke intervention, his technologies significantly enhance the precision and effectiveness of these critical medical procedures beyond the capabilities of existing systems. His award-winning flexible robot, recognized by the WHO as a future driver in 3D bioprinting and global health and named one of Thomson Reuters’ Top 4 Robots of the Year 2023, can perform both in-situ 3D bioprinting and endoscopic cancer surgery.
Dr. Do also developed non-blood-contacting bionic devices for heart failure patients, offering a safer option with reduced infection risks compared to traditional treatments. In the field of rehabilitation, his world-first smart robotic textiles expedite and personalize the recovery process, improving patient outcomes. Additionally, his internationally acclaimed soft haptic systems promise to create more immersive and intuitive experiences in various applications, from the emerging Metaverse to remote surgery, enriching digital experiences and expanding the boundaries of human-computer interaction.
2024